X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medicin och hälsovetenskap (107) 107
medical and health sciences (106) 106
female (88) 88
humans (88) 88
klinisk medicin (86) 86
clinical medicine (85) 85
oncology (67) 67
cancer och onkologi (62) 62
cancer and oncology (61) 61
index medicus (58) 58
middle aged (57) 57
aged (53) 53
adult (47) 47
cancer (29) 29
obstetrics & gynecology (25) 25
aged, 80 and over (23) 23
carcinoma (22) 22
prognosis (21) 21
neoplasm staging (20) 20
radiotherapy (20) 20
ovarian neoplasms - pathology (19) 19
surgery (19) 19
cervical cancer (17) 17
women (17) 17
chemotherapy (16) 16
ovarian neoplasms - drug therapy (15) 15
quality of life (15) 15
survival (14) 14
ovarian cancer (13) 13
surveys and questionnaires (13) 13
case-control studies (12) 12
quality-of-life (12) 12
care and treatment (11) 11
combined modality therapy (11) 11
survivors (11) 11
uterine cervical neoplasms - pathology (11) 11
endometrial cancer (10) 10
genital neoplasms, female - radiotherapy (10) 10
medicin (10) 10
medicine (10) 10
basic medicine (9) 9
medicinska och farmaceutiska grundvetenskaper (9) 9
ovarian neoplasms - mortality (9) 9
survival rate (9) 9
therapy (9) 9
time factors (9) 9
young adult (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
cervical-cancer (8) 8
immunohistochemistry (8) 8
kirurgi (8) 8
male (8) 8
research (8) 8
risk (8) 8
risk factors (8) 8
sweden (8) 8
antineoplastic agents - therapeutic use (7) 7
carcinoma, squamous cell - pathology (7) 7
cisplatin (7) 7
complications (7) 7
hematology, oncology and palliative medicine (7) 7
management (7) 7
ovarian neoplasms - therapy (7) 7
toxicity (7) 7
treatment outcome (7) 7
uterine cervix (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
consensus (6) 6
fecal incontinence (6) 6
follow-up studies (6) 6
paclitaxel (6) 6
patients (6) 6
prevalence (6) 6
radical hysterectomy (6) 6
radiotherapy - adverse effects (6) 6
reproduktionsmedicin och gynekologi (6) 6
tumors (6) 6
analysis (5) 5
cancer chemotherapy (5) 5
clinical-trials (5) 5
epidemiology (5) 5
follow-up (5) 5
genital neoplasms, female - diagnosis (5) 5
guidelines (5) 5
health aspects (5) 5
hysterectomy (5) 5
lymphedema (5) 5
medicine & public health (5) 5
nausea - chemically induced (5) 5
obstetrics and gynecology (5) 5
obstetrics, gynecology and reproductive medicine (5) 5
oncology, experimental (5) 5
ovarian neoplasms - diagnosis (5) 5
paclitaxel - administration & dosage (5) 5
paclitaxel - adverse effects (5) 5
pelvic radiotherapy (5) 5
practice guidelines as topic (5) 5
prospective studies (5) 5
radiation therapy (5) 5
radiologi och bildbehandling (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 01/2016, Volume 138, Issue 1, pp. 98 - 109
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3323 - 3329
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 11/2013, Volume 21, Issue 11, pp. 3063 - 3070
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 02/2009, Volume 104, Issue 2, pp. 130 - 137
:  The purpose of this study was to evaluate the role of sequence variants in the CYP2C8, ABCB1 and CYP3A4 genes and the CYP3A4 phenotype for the... 
BREAST-CANCER | GENETIC-VARIATION | METABOLISM GENES | PHARMACOKINETICS | IN-VIVO | PERIPHERAL NEUROPATHY | PHARMACOLOGY & PHARMACY | FUNCTIONAL-CHARACTERIZATION | TOXICOLOGY | HUMAN LIVER-MICROSOMES | CYTOCHROME-P450 3A4 | P-GLYCOPROTEIN | Cytochrome P-450 CYP2C8 | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Aryl Hydrocarbon Hydroxylases - genetics | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - pharmacokinetics | Paclitaxel - pharmacokinetics | Carboplatin - adverse effects | Ovarian Neoplasms - genetics | Carboplatin - therapeutic use | Cytochrome P-450 CYP3A - genetics | Polymerase Chain Reaction | Adult | Female | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Drug Administration Schedule | Carboplatin - administration & dosage | Paclitaxel - adverse effects | DNA Primers | Paclitaxel - therapeutic use | ATP Binding Cassette Transporter, Subfamily B | ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics | DNA - genetics | Pilot Projects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Polymorphism, Single Nucleotide | Chemotherapy | Oncology, Experimental | Cytochrome P-450 | Paclitaxel | Research | Universities and colleges | Drug therapy | Ovarian cancer | Cancer | Index Medicus | Pharmaceutical Sciences | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Medicinska och farmaceutiska grundvetenskaper | Farmaceutiska vetenskaper | MEDICINE
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2009, Volume 45, Issue 9, pp. 1700 - 1708
Journal Article
Lakartidningen, ISSN 0023-7205, 2018, Volume 115, Issue 46
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2017, Volume 23, Issue 5, pp. 1227 - 1235
Purpose: Neuropathy is the dose-limiting toxicity of paclitaxel and a major cause for decreased quality of life. Genetic factors have been shown to contribute... 
BREAST-CANCER | ONCOLOGY | TYROSINE KINASE | CORTICOSPINAL TRACT | RECEPTOR | INDUCED NEUROTOXICITY | SENSORY NEUROPATHY | KNOCKOUT MICE | IDENTIFICATION | GENOME-WIDE ASSOCIATION | CYP2C8-ASTERISK-3 | Receptor, EphA5 - genetics | Biomarkers, Pharmacological - analysis | Peripheral Nervous System Diseases - chemically induced | Genetic Association Studies | Humans | Middle Aged | Proportional Hazards Models | Paclitaxel - adverse effects | Receptor, EphA8 - genetics | Ovarian Neoplasms - complications | Breast Neoplasms - drug therapy | Breast Neoplasms - complications | Receptor, EphA6 - genetics | Quality of Life | Adult | Female | Aged | Peripheral Nervous System Diseases - pathology | Polymorphism, Single Nucleotide | Paclitaxel - administration & dosage | Peripheral Nervous System Diseases - genetics | Ovarian Neoplasms - drug therapy | Drugs | Toxicity | Genes | Risk | Peripheral neuropathy | Gene sequencing | Confidence intervals | Regression models | Neurotoxicity | Coding | Quality | Charcot-Marie-Tooth disease | Paclitaxel | Genetic factors | Statistical analysis | Markers | Pharmacology | Regression analysis | Patients | Quality of life | Genetic markers | Gene frequency | Experimental design | Pharmacokinetics | Cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Lakartidningen, ISSN 0023-7205, 2015, Volume 112, Issue 50, p. 2271
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2017, Volume 116, Issue 4, pp. 455 - 463
Journal Article
Läkartidningen, 2015, Volume 112
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 2013, Volume 50, Issue 9, pp. 599 - 605
Journal Article